Directory

>

Fred Vogt

avatar

Fred Vogt

Interim CEO and General Counsel | Iovance Biotherapeutics, Inc.

Pennsylvania, United States

View contact details (it's free)

Fred Vogt

Summary

Fred Vogt is an accomplished professional with extensive expertise in intellectual property law, particularly in patent law and litigation, alongside a strong background in biochemistry and biotechnology. Currently serving as the Interim CEO and General Counsel at Iovance Biotherapeutics, he combines his legal acumen with a deep understanding of the life sciences sector. With a Ph.D. in Chemistry and a J.D. from Temple University, Fred has held various influential roles, including patent attorney and manager at GlaxoSmithKline, where he led teams in the development of innovative therapeutic solutions. His academic contributions include numerous publications in prestigious journals, showcasing his commitment to advancing scientific knowledge. Fred is known for his ability to bridge the gap between complex scientific principles and legal frameworks, making him a valuable asset in any organization. His leadership experience spans both corporate and academic environments, reflecting a versatile career dedicated to excellence in the life sciences and legal fields.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Fred Vogt

Work Experience

company logo

Interim CEO and General Counsel at

Iovance Biotherapeutics, Inc.

September 2016 - Present

company logo

Associate Patent Attorney at

Morgan Lewis & Bockius LLP

May 2013 - September 2016

company logo

Adjunct Professor of Chemistry at

Villanova

August 2004 - June 2013

company logo

Patent Attorney/Manager, Product Development at

GSK

June 2000 - May 2013

💼

Chemist at

Betz Laboratories

January 1995 - August 1995

Logos provided by Logo.dev

Fred Vogt

Education

Temple University, Doctor Of Law (J.D.)

January 2008 - January 2012

Penn State University, Doctor Of Philosophy (Ph.D.)

January 1995 - January 2000

Ursinus College, Bachelor Of Science (B.S.)

January 1991 - January 1995

Frequently Asked Questions about Fred Vogt

What is Fred Vogt email address?

Fred Vogt's primary email address is *********@iovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Fred Vogt work for?

Fred Vogt is a Interim CEO and General Counsel at Iovance Biotherapeutics, Inc., a company specializing in Commercial physical research.

Where Fred Vogt graduated from?

Fred Vogt holds a degree in from Temple University.

How can I directly contact Fred Vogt?

To contact Fred Vogt directly, you can use the email address *********@iovance.com. Complete contact information is available upon registration with Muraena.

Who is Fred Vogt?

Fred Vogt is an accomplished professional with extensive expertise in intellectual property law, particularly in patent law and litigation, alongside a strong background in biochemistry and biotechnology. Currently serving as the Interim CEO and General Counsel at Iovance Biotherapeutics, he combines his legal acumen with a deep understanding of the life sciences sector. With a Ph.D. in Chemistry and a J.D. from Temple University, Fred has held various influential roles, including patent attorney and manager at GlaxoSmithKline, where he led teams in the development of innovative therapeutic solutions. His academic contributions include numerous publications in prestigious journals, showcasing his commitment to advancing scientific knowledge. Fred is known for his ability to bridge the gap between complex scientific principles and legal frameworks, making him a valuable asset in any organization. His leadership experience spans both corporate and academic environments, reflecting a versatile career dedicated to excellence in the life sciences and legal fields.

Fred`s contact details

mail

*********@iovance.com

***********@gsk.com

Colleagues

avatar
Selda Samakoglu Md

Executive Director, Clinical Development, Oncology

avatar
Stephen Camiolo

Vice President, Cell Therapy Account Teams

avatar
Peter Prieto Md Mph Cmq Facs Fsso

Senior Vice President, Medical Affairs

avatar
Ahmed Tawashi

Vice President, Research Alliances

avatar
Friedrich Graf Finckenstein

Chief Medical Officer

Gary Chen

Executive Director

Brian Shew

SVP Head of Digital and Information Technology

Pharm Guy Ruble Rac-Drugs

Vice President, Regulatory Affairs

avatar
Ryan Yamagata

Executive Director, CMC Biostatistics

Tim Logan

VP, Global Commercial Operations

View Contact details (it's free)
Request Profile Removal